GNOM US · ETF FactsheetGlobal X Genomics & Biotechnology ETF
Generated by Nukoud (nukoud.com) for informational purposes only — not investment advice, a recommendation, or an offer to buy or sell any security. Data is sourced from third-party providers and may be delayed or inaccurate. Past performance is not indicative of future results.
Global X Genomics & Biotechnology ETF
Exchange-Traded FundTechnical indicators
End of dayMoving averages
- 20-day SMA
- 67.2546 USD-3.14%Bearish
- 50-day SMA
- 66.9388 USD-2.69%Bearish
- 100-day SMA
- 62.7690 USD+3.78%Bullish
- 200-day SMA
- 54.5640 USD+19.38%Bullish
- 12-day EMA
- 66.7484 USD-2.41%Bearish
- 26-day EMA
- 67.0504 USD-2.85%Bearish
Oscillators
Sign in for the oscillators
RSI, MACD, Bollinger position and volatility for this fund — plus signal changes across every listing Nukoud tracks. A free account covers it.
Checking your session…Range & bands
Calculated from end-of-day closing prices. They describe how this fund has already traded, not what it will do next, and are information only — not advice.
About this fund
Global X Genomics & Biotechnology ETF (GNOM) is a Thematic and Technology ETF managed by Global X Management Company LLC, listed on Nasdaq - All Markets, quoted in USD. It charges a 0.50% net expense ratio and holds $105.76M in assets as of Nov 11, 2026. The fund launched on Apr 5, 2019.
- Benchmark
- Solactive GenomicsNet return, USD
- Distribution
- Semi-Annually
- AUM
- $105.76M
- Expense Ratio
- 0.50%
- Yield (12-mo)
- -0.30%
- Morningstar Rating
- Benchmark
- Solactive Genomics
- 52-Week Range
- Avg Daily Vol
- 35.6K
- Inception
- Apr 5, 2019
Risk metrics
vs benchmark Solactive Genomics · Net return, USD
3-year risk statistics are not currently available for this fund.
Risk statistics are 3-year, month-end-based.
Trailing returns
As of Nov 11, 2026Calendar-year returns
Morningstar daily closesTrading & liquidity
as of Nov 11, 2026
Average daily share volume over each trailing window. Spread is the average bid-ask spread as a percentage of price — lower means cheaper to trade.
Top 10 holdings
Source: MorningstarFees & expenses
Distributions
12-month yield
Recent payments per share (USD)
Classification
- Category
- Equity – Sector
- Asset class
- Equity
- Strategy
- Passive
- Themes
- BiotechnologyGenomics
- Sector
- Health Care
- Issuer
- Global X Management Company LLC
- Branding
- Global X
Similar ETFs
Funds sharing the same category or exposures.
- IBBUS$11.34B0.440%+29.37%
iShares Biotechnology ETF
Same category · Same sector · biotechnology
- ARKGUS$1.97B0.750%+59.75%
ARK Genomic Revolution ETF
Same category · Same sector · genomics
- HELXUS$34.82M0.500%+20.54%
Franklin Genomic Advancements ETF
Same category · Same sector · genomics
- XLVUS$50.35B0.080%+23.57%
State Street® Health Care Select Sector SPDR® ETF
Same category · Same sector
- VGTUS$167.05B0.090%+21.11%
Vanguard Information Technology Index Fund
Same group
- XLKUS$112.79B0.080%+21.54%
State Street® Technology Select Sector SPDR® ETF
Same group
Frequently asked questions
- What is GNOM's expense ratio?
- Global X Genomics & Biotechnology ETF charges a net expense ratio of 0.500%.
- How large is Global X Genomics & Biotechnology ETF?
- GNOM holds $105.76M in assets under management.
- What index does GNOM track?
- Global X Genomics & Biotechnology ETF tracks Solactive Genomics as its primary benchmark.
- When did GNOM launch?
- Global X Genomics & Biotechnology ETF launched on April 5, 2019.
- What currency does GNOM trade in?
- GNOM trades in USD on Nasdaq - All Markets.
Fund information
- Ticker
- GNOM
- Performance ID
- 0P0001DF3N
- Inception
- Apr 5, 2019
- Domicile
- USA
- Base currency
- USD
- Listing currency
- USD
- AUM
- $105.76M
- Avg daily volume (3M)
- 35.6K
Charting by TradingView.
